Kailera Therapeutics, Inc. (KLRA)
11.16
-0.17
(-1.50%)
USD |
NASDAQ |
Oct 13, 10:40
Kailera Therapeutics Market Cap : 1.447B for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 1.469B |
| October 09, 2026 | 1.505B |
| October 08, 2026 | 1.296B |
| October 07, 2026 | 1.365B |
| October 06, 2026 | 1.404B |
| October 05, 2026 | 1.405B |
| October 02, 2026 | 1.347B |
| October 01, 2026 | 1.430B |
| September 30, 2026 | 1.480B |
| September 29, 2026 | 1.425B |
| September 28, 2026 | 1.441B |
| September 25, 2026 | 1.454B |
| September 24, 2026 | 1.553B |
| September 23, 2026 | 1.702B |
| September 22, 2026 | 1.658B |
| September 21, 2026 | 1.554B |
| September 18, 2026 | 1.663B |
| September 17, 2026 | 1.675B |
| September 16, 2026 | 1.646B |
| September 15, 2026 | 1.743B |
| September 14, 2026 | 1.782B |
| September 11, 2026 | 1.807B |
| September 10, 2026 | 1.933B |
| September 09, 2026 | 1.924B |
| September 08, 2026 | 2.130B |
| Date | Value |
|---|---|
| September 04, 2026 | 2.104B |
| September 03, 2026 | 2.040B |
| September 02, 2026 | 2.054B |
| September 01, 2026 | 2.127B |
| August 31, 2026 | 1.996B |
| August 28, 2026 | 2.101B |
| August 27, 2026 | 2.402B |
| August 26, 2026 | 2.390B |
| August 25, 2026 | 2.301B |
| August 24, 2026 | 2.144B |
| August 21, 2026 | 2.226B |
| August 20, 2026 | 2.263B |
| August 19, 2026 | 2.375B |
| August 18, 2026 | 2.311B |
| August 17, 2026 | 2.399B |
| August 14, 2026 | 2.325B |
| August 13, 2026 | 2.329B |
| August 12, 2026 | 2.410B |
| August 11, 2026 | 2.446B |
| August 10, 2026 | 2.460B |
| August 07, 2026 | 2.418B |
| August 06, 2026 | 2.445B |
| August 05, 2026 | 2.354B |
| August 04, 2026 | 2.346B |
| August 03, 2026 | 2.244B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 9.370B |
| Prime Medicine, Inc. | 629.87M |
| GRAIL, Inc. | 6.119B |
| Arrowhead Pharmaceuticals, Inc. | 8.395B |
| Oncolytics Biotech, Inc. | 59.83M |
Market Cap Related Metrics
| Price to Book Value | 1.293 |
| Price | 11.16 |
| Earnings Yield | -15.15% |